CIK: 0001710065 · Show all filings
Period: Q4 2020 (Next →)
Filing Date: May 12, 2021
Total Value ($000): $264,256 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AVIR | ATEA PHARMACEUTICALS INC | 2,049,331 | $85,621 | 32.4% | $32.23 | 0.0% | COM | 04683R106 |
| APLS | APELLIS PHARMACEUTICALS INC | 1,114,962 | $63,776 | 24.1% | $42.30 | 0.0% | COM | 03753U106 |
| SEER | SEER INC | 1,066,375 | $59,866 | 22.7% | $63.62 | 0.0% | COM CL A | 81578P106 |
| KYMR | KYMERA THERAPEUTICS INC | 704,059 | $43,652 | 16.5% | $48.78 | 0.0% | COM | 501575104 |
| — | SUTRO BIOPHARMA | 175,000 | $3,799 | 1.4% | $21.71 | — | COM | 869367102 |
| — | CLEARSIDE BIOMEDICAL INC | 793,555 | $2,174 | 0.8% | $2.74 | — | COM | 185063104 |
| — | RAPT THERAPEUTICS INC | 108,503 | $2,143 | 0.8% | $19.75 | — | COM | 75382E109 |
| — | MOLECULAR TEMPLATES INC | 204,809 | $1,923 | 0.7% | $9.39 | — | COM | 608550109 |
| — | KEZAR LIFE SCIENCES INC | 128,916 | $673 | 0.3% | $5.22 | — | COM | 49372L100 |
| — | AILERON THERAPEUTICS INC | 517,558 | $538 | 0.2% | $1.04 | — | COM | 00887A105 |
| — | BELLICUM PHARMACEUTICALS INC | 25,651 | $91 | 0.0% | $3.55 | — | COM NEW | 079481404 |